BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

IntelGenx Corp. 

6425 Abrams Ville Street

Laurent  Quebec  H4S 1X9  Canada
Phone: 514-331-7440 Fax: 514-331-0436


SEARCH JOBS




Industry
Pharmaceutical






 Company News
IntelGenx Corp. To Present At The Rodman & Renshaw Global Investment Conference 8/21/2014 8:49:49 AM
IntelGenx Corp. Reports Q2, 2014 Results And Provides Corporate Development Update 8/7/2014 8:59:18 AM
IntelGenx Corp. To Host Management Call 7/21/2014 1:42:40 PM
IntelGenx Corp. Announces Equity Analyst Coverage By H.C. Wainwright 7/1/2014 8:46:30 AM
RedHill Biopharma Ltd. (RDHL) And IntelGenx Corp. Report Positive RHB-103 Bioavailability Study Results In Support Of Planned European Marketing Application In Q3/2014 5/21/2014 6:57:13 AM
IntelGenx Corp. Announces Government Of Canada Funding For CNS Versafilm™ Project 4/30/2014 10:00:04 AM
IntelGenx Corp. And RedHill Biopharma Ltd. (RDHL) Announce Commencement Of A Bioavailability Study With Anti-Migraine Versafilm™ Product To Support European Marketing Application Planned For Q3/2014 4/28/2014 9:10:31 AM
IntelGenx Corp. And RedHill Biopharma Ltd. (RDHL) Provide An Update On FDA's Ongoing Review Of The NDA For Migraine Versafilm™ Product 4/24/2014 8:58:22 AM
IntelGenx Corp. Announces Receipt Of An Additional U.S. Patent Allowance Related To Proprietary Technology 4/16/2014 9:25:47 AM
IntelGenx Corp. Reports 2013 Annual Results And Provides Corporate Development Update 3/11/2014 9:09:32 AM
12345678910...